Phase 3 study of Anturol for the treatment of overactive bladder (OAB) - MPR
Links shared publicly online about this topic.
- 1,344total visits
Phase 3 study of Anturol for the treatment of overactive bladder (OAB) - MPR
empr.com —
View full resource at empr.com
Tags: Overactive Bladder, Overactive Bladder Medication, Pharma, Phase 3 Clinical Trial, Ditropan, Gelnique, Oxytrol, Urotrol
Most Recently Shared on March 2, 2010 at 4:03 pm By:
MPR News: Phase 3 study of Anturol for the treatment of overactive bladder (OAB): Antares Pharma announced that it... http://bit.ly/bmHRqt
Phase 3 study of Anturol for the treatment of overactive bladder (OAB) - ONA
oncologynurseadvisor.com — “Antares Pharma announced that it has completed enrollment in the double-blind portion of their Phase 3 trial of Anturol (transdermal oxybutynin ATD gel) for the treatment of overactive bladder (OAB).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 2, 2010 at 3:58 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 study of Anturol for the treatment of overactive bladder (OAB) http://goo.gl/fb/FPaY
Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB
news-medical.net — “Antares Pharma, Inc. announced today that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol", its transdermal oxybutynin ATD" gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA), is expected in the third quarter of this year.” View full resource at news-medical.net
Most Recently Shared on March 2, 2010 at 2:08 pm By:
Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB: Antares Pharma, Inc. announced t... http://bit.ly/c5DxQc
Advertisement
